Patents by Inventor Aviva Gross

Aviva Gross has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Parenteral formulations of rasagiline
    Patent number: 9308182
    Abstract: This application provides a method of preferentially inhibiting monoamine oxidase A (MAOA) in the brain of a subject relative to in the intestine of the subject comprising parenterally administering to the subject a controlled release formulation comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: August 16, 2013
    Date of Patent: April 12, 2016
    Assignee: TEVA PHARMACEUTICAL INDUSTRIES, LTD.
    Inventors: Cheryl Fitzer-Attas, Rom E Eliaz, Eran Blaugrund, Aviva Gross, Adi Mayk
  • PARENTERAL FORMULATIONS OF RASAGILINE
    Publication number: 20140051767
    Abstract: This application provides a method of preferentially inhibiting monoamine oxidase A (MAOA) in the brain of a subject relative to in the intestine of the subject comprising parenterally administering to the subject a controlled release formulation comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 16, 2013
    Publication date: February 20, 2014
    Applicant: Teva Pharmaceutical Industries, Ltd.
    Inventors: Cheryl Fitzer-Attas, Rom E. Eliaz, Eran Blaugrund, Aviva Gross, Adi Mayk